Table 4.

Toxicity from IC between the two arms.

Adverse events	Nimotuzumab					Non-nimotuzumab					Z	P
	0	1	2	3	4	0	1	2	3	4
Hematologic
Leukopenia	10	31	45	23	11	8	39	38	22	13	-0.862	0.389
Neutropenia	12	24	38	20	26	14	26	36	16	28	-0.329	0.742
Anemia	83	26	8	3	0	86	22	10	2	0	-0.353	0.724
Thrombocytopenia	111	3	4	2	0	108	4	5	3	0	-0.687	0.492
Liver function	81	24	15	0	0	79	27	12	2	0	-0.225	0.822
Renal function	112	6	2	0	0	115	5	0	0	0	-0,877	0.380
Non-hematologic
Mucositis	105	10	5	0	0	107	11	2	0	0	-0.459	0.646
Dermatitis	114	6	0	0	0	117	3	0	0	0	-1.017	0.309
Diarrhea	106	10	3	1	0	112	6	2	0	0	-1.349	0.177
Nausea/vomiting	87	22	10	1	0	88	18	12	2	0	-0.002	0.998

Abbreviations: IC induction chemotherapy.